Luca Posa, Pharm.D.

Affiliations: 
2010-2014 Pharmacology Università di Bologna, Bologna, Italy 
 2012-2013 CNRS & Université Paris Descartes 
 2014-2015 Pharmacology CHU Ste. Justine, Universite de Montreal, Montréal, Québec, Canada 
 2015- Psychiatry McGill University, Montreal, QC, Canada 
Area:
opioid, melatonin, pain, tolerance
Google:
"Luca Posa"
Mean distance: 17.56 (cluster 32)
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Rullo L, Posa L, Caputi FF, et al. (2021) Nociceptive behavior and central neuropeptidergic dysregulations in male and female mice of a Fabry disease animal model. Brain Research Bulletin. 175: 158-167
De Gregorio D, Popic J, Enns JP, et al. (2021) Lysergic acid diethylamide (LSD) promotes social behavior through mTORC1 in the excitatory neurotransmission. Proceedings of the National Academy of Sciences of the United States of America. 118
Caputi FF, Di Cesare Mannelli L, Rullo L, et al. (2020) The active second-generation proteasome inhibitor oprozomib reverts the oxaliplatin-induced neuropathy symptoms. Biochemical Pharmacology. 182: 114255
De Gregorio D, Dean Conway J, Canul ML, et al. (2020) Effects of chronic exposure to low doses of Δ9- tetrahydrocannabinol in adolescence and adulthood on serotonin/norepinephrine neurotransmission and emotional behaviors. The International Journal of Neuropsychopharmacology
Comai S, De Gregorio D, Posa L, et al. (2020) Dysfunction of serotonergic activity and emotional responses across the light-dark cycle in mice lacking MT receptors. Journal of Pineal Research. e12653
López-Canul M, Min SH, Posa L, et al. (2019) Melatonin MT and MT Receptors Exhibit Distinct Effects in the Modulation of Body Temperature across the Light/Dark Cycle. International Journal of Molecular Sciences. 20
De Gregorio D, Enns JP, Nuñez NA, et al. (2018) d-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: Mechanism of action and potential therapeutic applications in mood disorders. Progress in Brain Research. 242: 69-96
De Gregorio D, McLaughlin RJ, Posa L, et al. (2018) Cannabidiol modulates serotonergic transmission and prevents allodynia and anxiety-like behavior in a model of neuropathic pain. Pain
Posa L, De Gregorio D, Gobbi G, et al. (2017) Targeting melatonin MT2 receptors: A novel pharmacological avenue for inflammatory and neuropathic pain. Current Medicinal Chemistry
De Gregorio D, Comai S, Posa L, et al. (2016) d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology. International Journal of Molecular Sciences. 17
See more...